Concepedia

Lilliam A. Rosario

LA

6

Publications

718

Citations

6

H-Index

2000

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Center for Toxicological Research

Fox Chase Cancer Center

Lilliam A. Rosario is an author at United States Food and Drug Administration specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2000–2020

6

Publications

6

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

Peter Bross, Robert C. Kane, Ann T. Farrell et al. · Clinical Cancer Research · 2004 · 336 citations · Full text

Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways.

J E Ruscoe, Lilliam A. Rosario, T Wang et al. · PubMed · 2001 · 165 citations

, , +17

Pharmacologic or Genetic Manipulation of Glutathione S-Transferase P1–1 (GSTπ) Influences Cell Proliferation Pathways

J E Ruscoe, Lilliam A. Rosario, Tieli Wang et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 92 citations

Cellular Response to a Glutathione<i>S</i>-Transferase P1-1 Activated Prodrug

Lilliam A. Rosario, Miechelle L. O’Brien, Colin J. Henderson et al. · Molecular Pharmacology · 2000 · 53 citations

FDA drug labeling: rich resources to facilitate precision medicine, drug safety, and regulatory science

Hong Fang, Stephen Harris, Zhichao Liu et al. · Drug Discovery Today · 2016 · 53 citations · Full text

, , +22

Rows per page

1–5 of 6